Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_assertion type Assertion NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_head.
- NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_assertion description "[It explains the lack of responsiveness to somatostatin analogue therapy of this tumor type, in contrast to the exquisite sensitivity of tumors that lack aggresomes, and has therapeutic implications for the safety of GH antagonism as a therapeutic modality in acromegaly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_provenance.
- NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_assertion evidence source_evidence_literature NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_provenance.
- NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_assertion SIO_000772 17671221 NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_provenance.
- NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_assertion wasDerivedFrom befree-2016 NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_provenance.
- NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_assertion wasGeneratedBy ECO_0000203 NP623145.RAKuRm3F6qkM_Kmvg3KT361yVCeGraSLXizDwdySjjbZQ130_provenance.